Lexis Nexis
 |    |  
Premier Destination for Sophisticated Buyers of Legal Services
Home > Law Firm Profile > People > Lawyer Profile

Gregory J. Wartman

  - Lawyer Profile
 



Gregory J. Wartman

Associate
 
Saul Ewing LLP
Centre Square West, 1500 Market Street, 38th Floor
Philadelphia, Pennsylvania  19102-2186
(Philadelphia Co.)

Telephone: 215-972-7777
Cable Address: "Bidsal"
TWX: 83-4798 Telecopier: XEROX 7020 215-972-7725
http://www.saul.com
Email: Contact via email

Visibility Rankings
#1,004 out of 10,855 lawyers in Philadelphia, Pennsylvania
#51,481 out of 892,905 total lawyers Overall


Experience & Credentials
 


Practice AreasLitigation
 
EducationUniversity of Pittsburgh School of Law, J.D., magna cum laude, 2001, University of Delaware, B.A., magna cum laude, 1998
 
Admitted2001, Pennsylvania
 
MembershipsPennsylvania and American Bar Associations.
 
BornBethlehem, Pennsylvania, November 6, 1976
 
BiographyPhi Beta Kappa; Order of the Coif. Author: "Freedom of Discrimination?: The Conflict Between Public Accomodations' Freedom of Association & State Anti-Discrimination Laws," 37 J. Marshall L. Rev. 125 (Fall 2003); "The Supreme Court's Inconsistent Treatment of Houseguests," Pitt. L. Rev., Issue 2, Vol. 62. Co-author: "Your Business in Court - 2006," Food and Drug Law Journal, Vol. 62, No. 2 (2007); "Amicus Curiae Efforts to Reform Product Liability at the Food and Drug Administration: FDA's Influence on Federal Preemption of Class III Medical Devices and Pharmaceuticals," Food and Drug Law Journal, Vol. 60, No. 4 (2005).
 
ISLN917158832
 

Articles by this firm on Martindale.com


Another Federal District Court Rules That FDA Labeling Regulations Preempt Some State Law Tort Claims
Gregory J. Wartman, April 10, 2008
A federal district court in Oklahoma recently ruled that a plaintiff's state law failure to warn claims against a prescription drug manufacturer are preempted by FDA regulations because FDA had considered and expressly rejected the plaintiff's proposed additional warning.

U.S. Supreme Court Rules Most State Law Tort Claims against Premarket Approved Medical Devices Preempted
Mark Carlisle Levy, Gregory J. Wartman, April 10, 2008
On February 20, 2008, the United States Supreme Court ruled that the 1976 Medical Device Amendments to the federal Food, Drug and Cosmetic Act preempts common law tort claims challenging the safety and effectiveness of a medical device approved by the premarket approval process.


Add lawyer to My Watch List

As a registered user of martindale.com you can add lawyers to your Watch List. You can securely add comments, compare lawyers in your Watch List, and access these lawyers with one click from your martindale.com homepage.

 

Compare this Lawyer

Compare this lawyer to other lawyers in your Watch List.








Total Practice Solutions

 
Terms & Conditions | Privacy | Copyright 2008 LexisNexis, a division of Reed Elsevier Inc. All rights reserved.